Rhode Island · 2025 Regular Session · Bill
HB 5463: AN ACT RELATING TO STATE AFFAIRS AND GOVERNMENT -- OFFICE OF HEALTH AND HUMAN SERVICES
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 5463 is a bill introduced in the Rhode Island House on February 12, 2025. According to its official title, it concerns: AN ACT RELATING TO STATE AFFAIRS AND GOVERNMENT -- OFFICE OF HEALTH AND HUMAN SERVICES. Primary sponsor: Arthur Handy (Democratic), Teresa Tanzi (Democratic), Rebecca Kislak (Democratic), Megan Cotter (Democratic), Cherie Cruz (Democratic), Brandon Potter (Democratic), Jennifer Stewart (Democratic). Most recent recorded action (April 30, 2025): 04/30/2025 Committee recommended measure be held for further study.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sponsors
Sponsors by party (alphabetical): Democratic 7
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Arthur Handy | Primary sponsor | Democratic | House | 18 |
| Teresa Tanzi | Primary sponsor | Democratic | House | 34 |
| Rebecca Kislak | Primary sponsor | Democratic | House | 4 |
| Megan Cotter | Primary sponsor | Democratic | House | 39 |
| Cherie Cruz | Primary sponsor | Democratic | House | 58 |
| Brandon Potter | Primary sponsor | Democratic | House | 16 |
| Jennifer Stewart | Primary sponsor | Democratic | House | 59 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- 04/30/2025 Committee recommended measure be held for further study
- 04/25/2025 Scheduled for hearing and/or consideration (04/30/2025)
- 02/12/2025 Introduced, referred to House Finance